RT Journal Article
SR Electronic
T1 Pathogenesis of Alzheimer’s disease: Involvement of the Choroid Plexus
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.07.29.21260696
DO 10.1101/2021.07.29.21260696
A1 Čarna, Maria
A1 Onyango, Isaac G.
A1 Katina, Stanislav
A1 Holub, Dušan
A1 Nezvedova, Marketa
A1 Jha, Durga
A1 Nedelska, Zuzana
A1 Lacovich, Valentina
A1 Vyvere, Thijs Vande
A1 Houbrechts, Ruben
A1 Garcia-Mansfield, Krystine
A1 Sharma, Ritin
A1 David-Dirgo, Victoria
A1 Vyhnalek, Martin
A1 Texlova, Kateřina
A1 Chaves, Hernan
A1 Bakkar, Nadine
A1 Pertierra, Lucia
A1 Vinkler, Mojmir
A1 Markova, Hana
A1 Laczo, Jan
A1 Sheardova, Kateřina
A1 Frič, Jan
A1 Pompeano, Antonio
A1 Forte, Giancarlo
A1 Kaňovsky, Petr
A1 Belaškova, Silvie
A1 Damborsky, Jiři
A1 Hort, Jakub
A1 Seyfried, Nicholas T.
A1 Bowser, Robert
A1 Sevlever, Gustavo
A1 Rissman, Robert A.
A1 Smith, Richard A.
A1 Hajduch, Marian
A1 Pirrotte, Patrick
A1 Spačil, Zdeněk
A1 Dammer, Eric B.
A1 Limbäck-Stokin, Clara
A1 Stokin, Gorazd B.
YR 2021
UL http://medrxiv.org/content/early/2021/12/16/2021.07.29.21260696.abstract
AB Aging and Alzheimer’s disease (AD), a major age-related disorder, are both characterized by inflammatory changes in the cerebrospinal fluid (CSF). The origin and the mechanisms underlying these inflammatory changes, however, remain poorly understood. Here, we report that aging elicits inflammatory changes in the CSF that become accentuated uniquely in AD compared to other inflammatory and neurodegenerative disorders. We show that the choroid plexus (ChP), which produces CSF, gains a pro-inflammatory profile, exhibits perturbed metabolism and contributes to the CSF changes observed in AD. We then use MRI imaging to establish a correlation between cognitive decline and increased volume of significantly remodelled ChP in patients with AD, and provide clinical relevance to the identified ChP pathology. These findings collectively suggest that ChP, unable to resolve inflammatory insults efficiently over the lifetime, participates in the inflammation and the pathogenesis of AD.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis study was supported by the European Regional Development Funds No. CZ.02.1.01/0.0/0.0/16_019/0000868 ENOCH grant (S.B., J.D., G.F., J.F., M.H., J.H., S.K. and G.B.S.), Research Infrastructure RECETOX RI grant (No LM2018121) financed by the Ministry of Education, Youth and Sports, and Operational Programme Research, Development and Innovation - CZ.02.1.01/0.0/0.0/17_043/0009632 CETOCOEN EXCELLENCE project, and the HORIZON 2020 No. 857560 (J.D., G.B.S. and Z.S.), the Czech Ministry of Health grants NV 18-04-00346 (Z.N.), NV 18-04-00455 and 00064203 (J.H.), NV19-08-00472 (Z.S. and K.S.), the No. CZ.02.1.01/0.0/0.0/16_026/0008451 INBIO grant (J.D.), NIH grant P30 AGO62429 (R.A.R.), the Barrow Neurological Foundation and the Fein Foundation (R.B.), the research infrastructure LM2018121 RECETOX grant (Z.S.), the Grant Agency of the Masaryk University No. MUNI/G/1131/2017 GAMU (Z.S.) and MUNI/A/1615/2020 (S.K.) grants, the National Cancer Institute of the NIH grant No. P30CA033572 (P.P.), the NIA U01 grant U01AG061357 (E.B.D. and N.T.S.) and the Institutional Support of Excellence 2. LF UK grant 6990332 (J.H.).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB/ethical approvals were obtaine from: Czech Brain Aging Study, St. Anne's University Hospital, Brno, and Motol Hospital, Prague, Barrow Neurological Institute, Phoenix, Alzheimer's Disease Neuroimaging Initiative, Buenos Aires, Argentina, Shiley-Marcos Alzheimer's Disease Research Centre, University of California San Diego, Imperial College Parkinson's UK Brain Bank I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll the data are available upon request once the manuscipt is published. https://www.synapse.org/#!Synapse:syn20835526